Drawing for MEDINTEL

USPTO serial 87447470

MEDINTEL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BUTTON, JENNIFER JO
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with MEDINTEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL K. LINDSEY

MICHAEL K LINDSEY GAVRILOVICH, DODD & LINDSEY LLP3303 N SHOWDOWN PLTUCSON, AZ 85749UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Medical testing services; medical testing services for detection, diagnostic or treatment purposes marketed and sold to healthcare providers and insurers, namely, third-party testing of patient urine, blood, and/or oral fluids, and skin or wound specimens; medical services, namely, medication monitoring and drug detection services to evaluate patient treatment plans to improve clinical outcomes and patient safety; drug use testing services, namely, testing patient urine, blood and/or oral fluid for medication or drug abuse and/or compliance with patient prescriptions; medical pharmacogenetic testing services for detection or treatment purposes that predict how a patient's genetic makeup may impact the patient's response to specific medications; medical testing services for detection of infectious disease; medical testing services for identification of appropriate antimicrobial therapy to improve clinical outcomesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 8, 2018MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Jan 6, 2018ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jan 6, 2018OP.TOPPOSITION TERMINATED NO. 999999—
Jan 6, 2018OP.SOPPOSITION SUSTAINED NO. 999999—
Sep 14, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Sep 14, 2017OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Aug 22, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 22, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 13, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 12, 2017DOCKASSIGNED TO EXAMINER—
May 18, 2017MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 17, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 16, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance